Experts point out some pitfalls that medtech companies should be aware of when trying to raise capital.
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Although transactions were down, they exceeded more than $450 million last month.
For medical device manufacturers, the American Invents Act created several challenges related to patent marking.
Analysts expect 2020 to be a busy year for M&A activity.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
How will you make your company more attractive to investors?
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.